 National Institute of Standards & Technology 

 

Certificate of Analysis 
Standard Reference Material® 2391b 

 

 
PCR-Based DNA Profiling Standard 
 
This  Standard  Reference  Material  (SRM)  is  intended  primarily  for  use  in  the  standardization  of  forensic  and 
paternity  quality  assurance  procedures  for  polymerase  chain  reaction  (PCR)-based  genetic  testing  and  for 
instructional law enforcement or non-clinical research purposes.  SRM 2391b can also be used for quality assurance 
when assigning values to in-house control materials.  It is not intended for any human or animal clinical diagnostic 
use.    Note  that  SRM 2391b  is  slightly  modified  from  SRM  2391  in  that  there  is  more  emphasis  on  short  tandem 
repeats (STRs), and certification of D1S80 has been dropped [1,2], reflecting the growing interest and utility of STRs  
[3–16].    Additional  information  on  each  STR  locus  can  be  found  at  a  NIST-sponsored  database  on  the  internet: 
http://www.cstl.nist.gov/biotech/strbase [14]. 
 
This SRM is composed of well-characterized human deoxyribonucleic acid (DNA) in two forms:  genomic DNA 
(components 1 through 10) and DNA to be extracted from cells that are spotted onto filter paper (components 11  
and 12).  A unit of SRM 2391b is composed of twelve frozen components packaged in one box.  See the section in 
this certificate entitled “Description of Components” and Table 1 for a complete listing of the components. 
 
Certified Values:  A NIST certified value is a value for which NIST has the highest confidence in its accuracy in 
that all known or suspected sources of bias have been investigated or taken into account [17].  The SRM is certified 
for genetic loci of forensic interest that were commercially available at the time of the certificate update.  Genetic 
types for these loci can be found in Tables 2 and 3.  The tables are organized as follows:  Table 2 lists the genetic 
types for the U.S. Federal Bureau of Investigation’s (FBI’s) CODIS (COmbined DNA Index System) core STR loci 
and Table 3 lists additional STR loci of interest.  Table 4 lists the genetic types for 26 non-CODIS (NC) miniSTR 
loci.  Certification of these NC miniSTR loci alleles is based on sequencing results in combination with genotyping 
results.    Those  allele  calls,  listed  in  Table 4  as  bold  font,  are  certified  values  based  on  the  presence  of  allele 
sequence  information  for  all  alleles  of  the  SRM  components  that  is  concordant  with  the  genotypes  obtained.  
Complete  sequencing 
the  SRM  components,  are  available  at 
http://www.cstl.nist.gov/biotech/strbase/srm2391b.htm. 
 
Reference  Values:    A  NIST  Reference  Value  is  a  best  estimate  of  the  true  value  provided  by  NIST  where  all 
known or suspected sources of bias have not been fully investigated by NIST [17].  Table 4 also lists the genetic 
types for 26 non-CODIS (NC) miniSTR loci in normal font that are considered reference values.  Reference values 
have been assigned when there is sequence information for only a few alleles of a particular locus.  The alleles that 
do not have sequence information for the components of this SRM are considered reference values in terms of the 
repeat count based on base pair (bp) size differences of an unsequenced allele compared to a sequenced allele for 
that locus.  While these are reference values there is confidence in their allele assignments. 
 
Expiration  of  Certification:    The  certification  of  SRM  2391b  is  valid,  within  the  measurement  uncertainties 
specified,  until  31  December  2013,  provided  the  SRM  is  handled  and  stored  in  accordance  with  the  instructions 
given  in  this  certification  (see  “Instructions  for  Use”).    The  certification  is  nullified  if  the  SRM  is  damaged, 
contaminated, or otherwise modified. 
 
The overall direction and coordination of the technical activities leading to certification were under the leadership of 
M.C. Kline of the NIST Biochemical Science Division. 

repeat  motifs 

listed  as 

results, 

for 

 
 
 
Gaithersburg, MD  20899 
Certificate Issue Date:  03 September 2008 
See Certificate Revision History on Last Page 

 SRM 2391b 

Laurie E. Locascio, Chief 
Biochemical Science Division 

Robert L. Watters, Jr., Chief 
Measurement Services Division 

Page 1 of 8 

 
Analytical determinations and technical measurements leading to the certification of this SRM were performed by 
staff of the NIST Biochemical Science Division:  M.C. Kline and J.W. Redman prepared the samples; M.C. Kline 
initially  evaluated  the  components  using  selected  PCR  amplification  kits  to  determine  the  certified  genotypes; 
A.E. Decker and M.C. Kline evaluated the stability of the components in selected quantitative PCR (qPCR) assays; 
C.R. Hill performed a concordance evaluation of the components by comparing the initial genotypes with recently 
obtained genotypes using short tandem repeat (STR) PCR amplification kits; and C.R. Hill performed sequencing 
and genotyping of 26 miniSTR loci to determine certified and reference values. 
 
Support  aspects  involved  in  the  issuance  of  this  SRM  were  coordinated  through  the NIST Measurement Services 
Division. 
 
The preparation of this SRM was supported in part by the National Institute of Justice, U.S. Department of Justice. 
 
Maintenance  of  SRM  Certification:    NIST  will  monitor  this  SRM  over  the  period  of  its  certification.    If 
substantive technical changes occur that affect the certification before the expiration of this certificate, NIST will 
notify the purchaser.  Registration (see attached sheet) will facilitate notification. 
 
NOTICE AND WARNINGS TO USER 

Storage:  Store frozen at a temperature of –20 ºC.  DO NOT use a self-defrosting freezer because periodic cycling 
of temperatures may cause shortened shelf life of this SRM.  Let the material warm up to lab ambient temperature 
for at least 2 hours before use.  Studies indicate that thawed material stored at 4 °C for several weeks resulted in an 
increased recovery of genomic DNA that had been adsorbed to the walls of the storage tubes.  For more stability 
information, see http://www.cstl.nist.gov/biotech/strbase/srm2391b.htm.  
 
Warning:  SRM 2391b IS A HUMAN SOURCE MATERIAL.  SINCE THERE IS NO CONSENSUS ON THE 
INFECTIOUS  STATUS  OF  EXTRACTED  DNA,  HANDLE  PRODUCT  AS  BIOSAFETY  LEVEL 1 
MATERIALS  CAPABLE  OF  TRANSMITTING  INFECTIOUS  DISEASE  [18].    SRM 2391b  components  and 
derived solutions should be disposed of in accordance with local, state, and federal regulations. 
 
INSTRUCTIONS FOR USE 

After opening the vials, sample aliquots for analysis should be withdrawn immediately and processed without delay 
for the certified values to be applicable. 
 
SOURCE AND ANALYSIS1 

Source of Material:  Genomic DNA components 1 through 8 were obtained from Roche Molecular Systems, Inc. 
(Alameda, CA).    Cell  Lines  GM09947A  and  GM09948  were  obtained  from  Marligen  Biosciences,  Inc. 
(Ijamsville, MD). 
 
Interlaboratory Analysis:  The STR values for this SRM represent the pooled results from analyses performed at 
NIST;  Pennsylvania  State  Police  DNA  Laboratory  (Greensburg,  PA);  Oregon  State  Police  Forensic  Laboratory 
(Portland, OR); Promega Corp. (Madison, WI); and Applied Biosystems (Foster City, CA).  A detailed list of the 
amplification kits used at NIST to obtain the STR values and other genetic loci types are shown in Table 5. 

                                                           
1  Certain  commercial  equipment,  instruments  or  materials  are  identified  in  this  certificate  to  adequately  specify  the 
 
experimental  procedure.    Such  identification  does  not  imply  recommendation  or  endorsement  by  the  National  Institute  of 
Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the 
purpose. 
SRM 2391b 

Page 2 of 8 

 
Description  of  Components:    Twelve  components  are  included  in  each  unit.    Components 1  through 10  each 
contain 20 µL of genomic DNA.  The DNA concentration ([DNA]) ranges are provided in Table 1 for information 
purposes  indicating  the  range  found  at  initial  thawing  through  one-month  storage  at  4 ºC.    Component A  of 
SRM 2372 Human DNA Quantitation Standard was used to calibrate the qPCR runs establishing the [DNA] ranges. 
 

Table 1.  Description of Components in SRM 2391b 
 
 
DNA Concentration Range(a) 
(ng/µL) 
 

 
 

Description 

No. of cells 
(on 7 mm Scleicher & Schull 903 
Filter Paper Circle) 

Component 
 
 

1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 

Genomic DNA 1  
Genomic DNA 2  
Genomic DNA 3  
Genomic DNA 4  
Genomic DNA 5  
Genomic DNA 6  
Genomic DNA 7  
Genomic DNA 8 
Genomic GM09947A  
Genomic GM09948  
Cell GM09947A 
Cell GM09948 

0.08 – 0.61  
0.17 – 0.89 
0.17 – 0.41 
0.21 – 0.49 
0.34 – 0.70 
0.24 – 0.72 
0.16 – 0.56 
0.42 – 0.87 
0.31 – 0.88 
0.33 – 0.87 

2 × 105 cells 
2 × 105 cells 

 
(a) DNA concentrations given are nominal values and are not intended for use as concentration standards. 
 
 
Typing results are shown in Tables 2 through 4.  All results are identical to those of SRM 2391a with the following 
quantitative exceptions: 

The relative intensities of the three alleles of GM09948 cell line at the HUMCSF1PO locus (CSF1PO) are not the 
same.  While this cell line was determined to be karyologically stable by Fregeau et al. [3], these authors did not 
study  the  CSF1PO  locus.    The  observed  CSF1PO  locus  differences  may  be  due  to  differences  in  cell  generation 
passage numbers of the two materials.  While less noticeable, these CSF1PO allele intensity differences have been 
present in the earlier SRM 2391 releases (see Figure 1 below). 
 
 
 

SRM 2391b 

Page 3 of 8 

 
 

2 

3 

4 

5 

6 

7 

8 

9 

 
 
 
 
 
 
 
 
 
 
 

10 

11 

12 

  

Component 
Number 
1 

Description 

CSF1PO 

D3S1358  D5S818  D7S820  D8S1179  D13S317  D16S539  D18S51 

D21S11 

FGA 

TH01 

TPOX 

vWA 

  
17,17 

Genomic 1 

29,33.2 

  9,10 

14,14 

12,14 

11,13 

21,22 

13,13 

14,17 

12,12 

12,12 

8,11 

6,7 

 

Table 2.  Certified Values for the FBI’s CODIS 13 STR Loci. 
 

Genomic 2 

11,12 

15,16 

12,12 

  9,10 

11,16 

8,11 

12,12 

10,14 

29,30 

20,22 

8,9.3 

8,10 

14,16 

Genomic 3 

11,12 

15,15 

11,11 

  12,13 

14,16 

11,12 

11,12 

16,20 

28,31.2 

23,25 

9.3,9.3

8,11 

18,19 

Genomic 4 

11,12 

15,17 

11,11 

  8,10 

14,14 

12,12 

18,18 

28,30 

18,22 

7,9 

8,9 

17,17 

Genomic 5 

10,12 

15,18 

11,12 

  8,10 

15,16 

11,12 

14,16 

28,30 

23,26 

7,7 

10,11 

16,20 

Genomic 6 

10,13 

14,17 

12,12 

  8,11 

10,16 

12,13 

12,13 

18,18 

28,29 

21,26 

9,9.3 

8,8 

16,18 

Genomic 7 

10,11 

14,15 

11,12 

  9,9 

13,15 

11,12 

10,10 

13,16 

28,31.2 

23,24 

6,7 

8,11 

16,16 

Genomic 8 

10,12 

15,18 

12,13 

9,10 

12,14 

9,13 

9,11 

15,18 

30,31 

24,28 

7,8 

8,12 

15,17 

10,12 

14,15 

11,11 

  10,11 

13,13 

11,11 

11,12 

15,19 

30,30 

23,24 

8,9.3 

8,8 

17,18 

 

 

 

 

 

 

 

 

10,11,12 

15,17 

11,13 

  11,11 

12,13 

11,11 

11,11 

15,18 

29,30 

24,26 

6,9.3 

8,9 

17,17 

  10,12 

14,15 

11,11 

  10,11 

13,13 

11,11 

11,12 

15,19 

30,30 

23,24 

8,9.3 

8,8 

17,18 

Genomic 
GM09947A 

Genomic 
GM09948 

GM09947A
Cells 

GM09948 
Cells 

 10,11, or 
 10,11,12(a) 

  

(a) The relative intensity of the 12 allele is less than 10 % of the dominant 10 allele.  See accompanying Figure 1 below. 

15,17 

11,13 

  11,11 

12,13 

11,11 

11,11 

15,18 

29,30 

24,26 

6,9.3 

8,9 

17,17 

9,10 

9,11 

) 

an 
cm  ee  ee 

2391 

2391la 

2391b

Figure 1.  Relative intensities of the three CSF1PO alleles of GM09948 cell line in different lots of 2391. 

SRM 2391b 

Page 4 of 8 

 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

Table 3.  Certified Values for Additional STR Loci Available in Manufactured Kit Form. 
 
  
Component 
Number 

  

Amelogeni
n 

D2S1338  D19S433 

F13B  FES/FPS 

F13A0
1 

Penta  
E 

Penta 
D 

Description 

SE33 

LPL 

Genomic 1 

X,Y 

6,7 

10,10 

12,12 

10,11 

10,15 

7,12 

17,23 

13,16.2 

20,30.2 

Genomic 2 

X,X 

7,7 

8,10 

10,11 

10,11 

9,11 

7,12 

17,26 

14,16 

23.2,28.2 

Genomic 3 

X,Y 

3.2,4 

9,10 

11,12 

11,12 

11,12 

13,14 

20,24 

12,14 

14.2,26.2 

Genomic 4 

X,X 

5,6 

6,9 

10,13 

10,12 

8,9 

5,12 

17,23 

11,13 

22,28.2 

Genomic 5 

X,X 

5,7 

8,9 

11,13 

10,12 

10,13 

7,13 

17,19 

12.2,14 

14,30.2 

Genomic 6 

X,X 

3.2,5 

9,10 

11,11 

10,12 

9,12 

12,14 

25,25 

12,14 

20,21 

Genomic 7 

X,Y 

5,8 

6,8 

11,11(a) 

11,12 

3.2,11 

12,16 

17,22 

13,15.2 

13.2,20 

Genomic 8 

X,X 

3.2,5 

6,8 

10,11 

9,11 

8,9 

5,10 

22,22 

12.2,15 

16,27.2 

X,X 

6,16 

8,10 

10,12 

11,12 

12,12 

12,13 

19,23 

14,15 

19,29.2 

6,6 

8,8 

11,11 

10,12 

8,12 

11,11 

23,23 

13,14 

23.2,26.2 

6,16 

8,10 

10,12 

11,12 

12,12 

12,13 

19,23 

14,15 

19,29.2 

Genomic 
GM09947
A 
Genomic 
GM09948 
GM09947
A Cells 
GM09948 
Cells 

X,Y 

X,X 

X,Y 

  

6,6 

8,8 

11,11 

10,12 

8,12 

11,11 

23,23 

13,14 

23.2,26.2 

(a) Genomic 7 has a variant allele at the FES/FPS locus.  Many analysis systems type this as an 11 homozygote; however, this sample displays an 11 
  and a variant allele, 10.3, when separated in a Genetic Analyzer 3130xl Capillary Electrophoresis unit used at NIST as shown in Figure 2 below.  
  Preliminary  sequence  information  of  this  variant  allele  indicates  two  sequence  changes:  one  on  either  side  of  the  repeat  region  resulting  in  an 
  electrophoretic mobility shift. 
 
 
 
 

  

FESFPS 

250   
2410 

220 

230 

300 

400 

300 

100 

 
    

 

Figure 2.  Genetic Analyzer 3130 xl Capillary Electrophoresis of FES/FPS locus, Genomic 7 sample. 
 

SRM 2391b  

Page 5 of 8 

 

  

 

Locus 

D1GATA113 
D1S1627 
D1S1677  
D2S441  
D2S1776 
D3S3053 
D3S4529 
D4S2364  
D4S2408 
D5S2500 
D6S474 
D6S1017 
D8S1115 
D9S1122 
D9S2157 

D10S1248  
D10S1435 
D11S4463 
D12ATA63 

D14S1434  
D17S974 
D17S1301 
D18S853 
D20S482 
D20S1082 
D22S1045  

11,11 
10,14 
12,13 
11,14 
11,12 
9,12 
14,15 
9,9 
10,10 
17,18 
15,17 
10,10 
16,16 
11,12 
8,13 

14,16 
13,13 
14,14 
14,17 

13,14 
9,11 
11,11 
11,14 
14,14 
11,15 
14,15 

Table 4.  Certified Values and Reference Values for Additional Genetic Loci Alleles Not Commercially Available in Kit Format(a). 
Genomic 
6 

Genomic 10 
- 9948 

Genomic 9 
- 9947A 

Genomic 
5 

Genomic 
4 

Genomic 
2 

Genomic 
7 

Genomic 
3 

Genomic 
8 

Genomic 
1 

Cells  11 
- 9947A 

Cells12 - 
- 9948 

12,13 
13,14 
14,16 
11,14 
11,11 
10,11 
13,16 
9,10 
9,9 
17,24 
14,17 
10,12 
16,16 
12,13 
9,11 

13,15 
11,14 
13,14 
13,17 

11,13 
9,10 
11,12 
11,11 
14,16 
14,15 
11,16 

11,11 
13,14 
14,17 
10,14 
8,10 
9,11 
14,16 
9,10 
8,9 
17,18 
14,15 
10,12 
16,17 
12,12 
11,13 

13,16 
13,14 
14,15 
12,15 

14,15 
9,9 
11,12 
11,11 
15,15 
11,11 
15,16 

13,13 
11,12 
14,15 
12,14 
11,12 
11,11 
15,16 
9,9 
9,10 
17,18 
14,16 
7,10 
9,17 
12,12 
11,11 

12,12 
12,12 
11,12 
16,18 

10,11 
7,9 
12,13 
11,13 
14,15 
14,15 
17,18 

11,12 
14,15 
13,14 
11,14 
12,13 
11,11 
13,15 
9,10 
10,11 
14,15 
15,18 
8,9 
9,15 
11,13 
7,14 

14,15 
11,12 
14,16 
13,15 

13,14 
11,12 
11,11 
10,15 
14,15 
11,14 
11,14 

11,12 
11,13 
13,14 
10,11 
11,12 
9,9 
15,17 
8,9 
9,9 
14,18 
14,17 
10,10 
9,16 
11,12 
11,13 

14,15 
12,12 
16,17 
14,18 

13,14 
9,9 
11,11 
11,14 
14,14 
11,15 
11,15 

10,12 
11,14 
12,13 
11,14 
11,12 
11,11 
14,16 
9,9 
8,11 
14,20 
15,17 
7,12 
9,18 
11,12 
12,15 

13,14 
12,12 
14,15 
16,17 

10,14 
11,11 
11,12 
14,14 
14,14 
14,15 
11,15 

10,12 
13,14 
14,16 
11,11.3 
11,12 
9,9 
14,14 
9,9 
11,11 
14,18 
17,17 
10,12 
15,16 
13,13 
11,11 

11,15 
11,13 
14,17 
14,15 

13,13 
8,9 
12,12 
12,13 
15,16 
11,15 
16,17 

11,12 
13,14 
13,14 
10,14 
10,10 
9,11 
13,13 
9,10 
9,10 
14,23 
14,18 
9,10 
9,18 
12,13 
7,13 

13,15 
10,11 
12,13 
13,13 

11,13 
7,10 
12,12 
11,14 
14,15 
11,14 
11,14 

7,12 
11,13 
13,14 
11,12 
10,12 
9,12 
12,12 
9,10 
10,10 
14,17 
17,17 
8,8 
15,17 
12,15 
7,11 

12,15 
12,13 
12,14 
13,18 

13,14 
10,11 
11,12 
11,11 
13,14 
11,15 
16,18 

11,12 
13,14 
13,14 
10,14 
10,10 
9,11 
13,13 
9,10 
9,10 
14,23 
14,18 
9,10 
9,18 
12,13 
7,13 

13,15 
10,11 
12,13 
13,13 

11,13 
7,10 
12,12 
11,14 
14,15 
11,14 
11,14 

7,12 
11,13 
13,14 
11,12 
10,12 
9,12 
12,12 
9,10 
10,10 
14,17 
17,17 
8,8 
15,17 
12,15 
7,11 

12,15 
12,13 
12,14 
13,18 

13,14 
10,11 
11,12 
11,11 
13,14 
11,15 
16,18 

(a) All allele calls listed in bold print are certified values.  All allele calls that are in normal print are reference values. 
 

SRM 2391b  

 

Page 6 of 8 

Table 5.  Commercially Available Amplification “Kits” Used at NIST to Genotype STR Loci. 
 

Applied Biosystems 

Promega 

Genetic 
Locus 

Identifile
r 

Profiler 
Plus 

COfiler 

MiniFiler 

SGM 
Plus 

Power 
Plex 16 

Power 
Plex ES 

FFFL 

Power 
Plex 16 
BIO 

× 

× 
× 
× 
× 
× 
× 
× 
× 
× 
× 
× 
  
  
  
× 
  
  
  
  
× 
× 
× 

× 

  
  
  
× 
× 
× 
× 
  
× 
  
× 
  
  
  
× 
  
  
  
  
  
  
× 

× 

× 
  
× 
  
× 
  
  
× 
  
  
  
  
  
  
  
  
  
  
  
× 
× 
  

× 

  
× 
× 
  
  
× 
  
× 
× 
× 
× 
  
  
  
× 
  
  
  
  
× 
  
× 

× 

× 
× 
  
  
× 
  
× 
× 
× 
  
× 
  
  
  
× 
  
  
  
  
  
  
  

× 

× 
  
× 
× 
× 
× 
× 
× 
× 
  
× 
  
  
  
× 
  
× 
× 
  
× 
× 
× 

× 

  
  
× 
  
  
× 
  
  
× 
  
× 
  
  
  
× 
  
  
  
× 
× 
  
× 

× 

× 
  
× 
× 
× 
× 
× 
× 
× 
  
× 
  
  
  
× 
  
× 
× 
  
× 
× 
× 

  

  
  
  
  
  
  
  
  
  
  
  
× 
× 
× 
  
× 
  
  
  
  
  
  

 

  

Amelogeni
n 
CSF1PO 
D2S1338 
D3S1358 
D5S818 
D7S820 
D8S1179 
D13S317 
D16S539 
D18S51 
D19S433 
D21S11 
F13A01 
F13B 
FES/FPS 
FGA 
LPL 
PENTA D 
PENTA E 
SE33 
TH01 
TPOX 
vWA 

 

 

SRM 2391b  

Page 7 of 8 

 

REFERENCES 

 
[1]  Nakamura, Y.; Carlson, M.; Krapcho, V.; White, R.; Isolation and Mapping of a Polymorphic DNA Sequence 

(pMCT118) on Chromosome 1p (D1S80); Nucleic Acids Res., Vol. 16, p. 9364 (1988). 

[2]  Kasai, K.; Nakamura, Y.; White, R.; Amplification of a Variable Number of Tandem Repeats (VNTR) Locus 
(pMCT118)  by  the  Polymerase  Chain  Reaction  (PCR)  and  its  Application  to  Forensic  Science;  J.  Forensic 
Sci., Vol. 35, pp. 1196–1200 (1990). 

[3]  Fregeau,  C.J.;  Fourney,  R.M.;  DNA  Typing  With  Fluorescently  Tagged  Short  Tandem  Repeats:  A  Sensitive 

and Accurate Approach to Human Identification; BioTechniques, Vol. 15, pp. 100–119 (1993). 

[4]  Budowle, B.; Moretti, T.R.; Niezgoda, S.J.; Brown, B.L.; CODIS and PCR-Based Short Tandem Repeat Loci: 
Law Enforcement Tools; Proceedings of the Second European Symposium on Human Identification, Promega 
Corporation, Madison, WI (1998); available at http://www.promega.com/geneticidproc/eusymp2proc/17.pdf. 

[5]  Budowle,  B.;  Moretti,  T.R.;  Baumstark,  A.L.;  Defenbaugh,  D.A.;  Keys,  K.M.;  Population  Data  on  the 
Thirteen  CODIS  Core  Short  Tandem  Repeat  Loci  in  African  Americans,  U.S.  Caucasians,  Hispanics, 
Bahamians, Jamaicans, and Trinidadians; J. Forensic Sci., Vol. 44, pp. 1277–1286 (1999). 

[6]  Budowle, B.; Smith, J.; Moretti, T.; DiZinno, J.A.; DNA Typing Protocols: Molecular Biology and Forensic 

[7]  Butler,  J.M.;  Forensic  DNA  Typing:  Biology,  Technology,  and  Genetics  of  STR  Markers,  2nd  ed.;  Elsevier 

Analysis; BioTechniques Books: Eaton, MA (2000). 

Academic Press: Berlington, MA (2005).  

[8]  Edwards, A.; Civitello, A.; Hammond, H.A.; Caskey, C.T.; DNA Typing and Genetic Mapping With Trimeric 

and Tetrameric Tandem Repeats; Am. J. Hum. Genet., Vol. 49, pp. 746–756 (1991). 

[9]  Gill,  P.;  Evett,  I.;  Population  Genetics  of  Short  Tandem  Repeat  (STR)  Loci;  Genetica.  Vol. 96;  pp. 69–87 

(1995). 

[10]  Gill, P.; Urquhart, A.; Millican, E.S.; Oldroyd, N.J.; Watson, S.; Sparkes, R.; Kimpton, C.P.; A New Method of 
STR Interpretation Using Inferential Logic – Development of a Criminal Intelligence Database; Int. J. Legal 
Med., Vol. 109, Issue 1, pp. 14–22 (1996). 

[11]  Gill,  P.;  Koumi,  P.;  Allen,  H.;  Sizing  Short  Tandem  Repeat  Alleles  in  Capillary  Array  Gel  Electrophoresis 

Instruments; Electrophoresis, Vol. 22, pp. 2670–2678 (2001). 

[12]  Kimpton,  C.P.;  Gill,  P.;  Walton,  A.;  Urquhart,  A.;  Millican,  E.S.;  Adams,  M.;  Automated  DNA  Profiling 
Employing Multiplex Amplification of Short Tandem Repeat Loci; PCR Meth. Appl., Vol. 3, pp. 13–22 (1993). 
[13]  Lazaruk, K.; Walsh, P.S.; Oaks, F.; Gilbert, D.; Rosenblum, B.B.; Menchen, S.; Scheibler, D.; Wenz, H.M.; 
Holt, C.; Wallin, J.; Genotyping of Forensic Short Tandem Repeat (STR) Systems Based on Sizing Precision in 
a Capillary Electrophoresis Instrument; Electrophoresis, Vol. 19, pp. 86–93 (1998). 

[14]  Ruitberg, C.M.; Reeder, D.J.; Butler, J.M.; STRBase: A Short Tandem Repeat DNA Database for the Human 

Identity Testing Community; Nucleic Acids Res., Vol. 29, pp. 320–322 (2001). 

[15]  Fregeau, C.J.; Aubin, R.A.; Elliott, J.C.; Gill, S.S.; Fourney, R.M.; Characterization of Human Lymphoid Cell 
Lines GM9947 and GM9948 as Intra- and Interlaboratory Reference Standards for DNA Typing; Genomics, 
Vol. 28, pp. 184–197 (1995). 

[16]  Hill,  C.R.,  Kline,  M.C.,  Coble,  M.D.,  Butler,  J.M.,  Characterization  of  26  MiniSTR  Loci  for  Improved 

Analysis of Degraded DNA Samples, J. Forensic Sci., Vol. 53, No. 1, pp. 73–80 (2008) 

[17]  May, W.E.;  Gills, T.E.;  Parris, R.;  Beck, II, C.M.;  Fassett, J.D.;  Gettings, R.J.;  Greenberg, R.R.; 
Guenther, F.R.; Kramer, G.; MacDonald, B.S.; Wise, S.A.; Definitions of Terms and Modes Used at NIST for 
Value-Assignment  of  Reference  Materials  for  Chemical  Measurements;  NIST  Special  Publication 260-136 
(2000); available at http://ts.nist.gov/MeasurementServices/ReferenceMaterials/PUBLICATIONS.cfm. 
[18]  CDC/NIH; Biosafety in Microbiological and Biomedical Laboratories, 5th ed.; Richardson, J.; Barkley, W.E.; 
Richmond, J.; McKinney, R.W., Eds.; U.S. Department of Health and Human Services, Public Health Service, 
Centers for Disease Control and Prevention and National Institutes of Health; US Government Printing Office: 
Washington, D.C. (2007); available at http://www.cdc.gov/OD/OHS/biosfty/bmbl5/BMBL_5th_Edition.pdf. 

 
Certificate  Revision  History:    03  September  2008  (Extension  of  certificate  period  and  editorial  revisions);  06  December  2002  (Original 
certificate issue date).  
 
Users  of  this  SRM  should  ensure  that  the  certificate in their possession is current.  This can be accomplished by 
contacting the SRM Program at:  telephone (301) 975-6776; fax (301) 926-4751; e-mail srminfo@nist.gov; or via 
the Internet at http://www.nist.gov/srm. 

SRM 2391b  

Page 8 of 8 

